Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO31 Inhibitors

FBXO31 inhibitors belong to a class of chemical compounds designed to selectively target and modulate the activity of F-box only protein 31 (FBXO31). FBXO31 is a member of the F-box protein family, which serves as a key component of the Skp1-Cullin-F-box (SCF) ubiquitin ligase complex. This complex plays a central role in the regulation of protein stability by marking specific target proteins for ubiquitin-mediated proteasomal degradation. FBXO31 functions as the F-box protein within this complex, recognizing and binding to specific target proteins that are to be ubiquitinated and subsequently degraded. The design of FBXO31 inhibitors typically involves creating molecules that can selectively bind to FBXO31, potentially disrupting its interactions with target proteins or modulating its substrate recognition and ubiquitination activity. FBXO31 inhibitors are developed through chemical synthesis and structural optimization techniques, with the primary goal of interfering with the function of FBXO31 within the SCF ubiquitin ligase complex. By modulating FBXO31 activity, these inhibitors have the potential to impact the ubiquitin-mediated degradation of specific cellular proteins, thereby influencing various cellular processes, including cell cycle regulation, signal transduction, and protein quality control. The study of FBXO31 inhibitors provides valuable insights into the intricate molecular mechanisms governing protein turnover and degradation, offering a deeper understanding of the fundamental processes that underlie cellular homeostasis. This research contributes to our knowledge of basic cell biology and the regulatory networks that maintain protein stability and cellular function.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that might indirectly affect the ubiquitin-proteasome system and the function of F-box proteins like FBXO31.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Another proteasome inhibitor, bortezomib could influence the degradation pathways and potentially impact FBXO31 expression.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

A specific inhibitor of the proteasome, lactacystin might affect the stability and function of proteins like FBXO31.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

Inhibits NEDD8-activating enzyme, affecting ubiquitination processes, potentially influencing FBXO31 expression.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Disrupts the MDM2-p53 interaction, potentially influencing cell cycle pathways and F-box protein expression like FBXO31.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

A CDK4/6 inhibitor, palbociclib might affect cell cycle regulation and indirectly influence FBXO31 expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

An HDAC inhibitor, trichostatin A affects chromatin structure and gene expression, potentially impacting FBXO31.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Another HDAC inhibitor, vorinostat alters gene expression patterns and could potentially impact FBXO31 expression.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

A PARP inhibitor, olaparib is involved in DNA damage response and could indirectly affect FBXO31 expression.

VE 821

1232410-49-9sc-475878
10 mg
$360.00
(0)

Inhibits ATR kinase, a key player in DNA damage response, potentially influencing FBXO31 expression.